18F-FDG-PET/CT and diffusion-weighted MRI for monitoring a BRAF and CDK 4/6 inhibitor combination therapy in a murine model of human melanoma.

about

18F-FDG-PET/CT and diffusion-weighted MRI for monitoring a BRAF and CDK 4/6 inhibitor combination therapy in a murine model of human melanoma.

Item

http://www.wikidata.org/entity/Q49770136

description

2018 nî lūn-bûn

@nan

2018年の論文

@ja

2018年学术文章

@wuu

2018年学术文章

@zh

2018年学术文章

@zh-cn

2018年学术文章

@zh-hans

2018年学术文章

@zh-my

2018年学术文章

@zh-sg

2018年學術文章

@yue

2018年學術文章

@zh-hant

name

18F-FDG-PET/CT and diffusion-w ...... urine model of human melanoma.

@en

18F-FDG-PET/CT and diffusion-w ...... urine model of human melanoma.

@nl

type

Item

label

18F-FDG-PET/CT and diffusion-w ...... urine model of human melanoma.

@en

18F-FDG-PET/CT and diffusion-w ...... urine model of human melanoma.

@nl

prefLabel

18F-FDG-PET/CT and diffusion-w ...... urine model of human melanoma.

@en

18F-FDG-PET/CT and diffusion-w ...... urine model of human melanoma.

@nl

P1476

18F-FDG-PET/CT and diffusion-w ...... urine model of human melanoma.

@en

P2093

Andrei Todica

http://www.w3.org/2001/XMLSchema#string

Clemens C Cyran

http://www.w3.org/2001/XMLSchema#string

Georg Keinrath

http://www.w3.org/2001/XMLSchema#string

Heidrun Hirner-Eppeneder

http://www.w3.org/2001/XMLSchema#string

Jens Ricke

http://www.w3.org/2001/XMLSchema#string

Jessica Olivier

http://www.w3.org/2001/XMLSchema#string

Maurice M Heimer

http://www.w3.org/2001/XMLSchema#string

Maximilian F Reiser

http://www.w3.org/2001/XMLSchema#string

Moritz J Schneider

http://www.w3.org/2001/XMLSchema#string

Olga Solyanik

http://www.w3.org/2001/XMLSchema#string

P2860

Combined BRAF and MEK inhibition in melanoma with BRAF V600 mutations

Resistant mechanisms to BRAF inhibitors in melanoma

Resistance to BRAF inhibitors: unraveling mechanisms and future treatment options

Reversible and adaptive resistance to BRAF(V600E) inhibition in melanoma.

Improved overall survival in melanoma with combined dabrafenib and trametinib.

The cyclin-dependent kinase 4/6 inhibitor palbociclib in combination with letrozole versus letrozole alone as first-line treatment of oestrogen receptor-positive, HER2-negative, advanced breast cancer (PALOMA-1/TRIO-18): a randomised phase 2 study.

New response evaluation criteria in solid tumours: revised RECIST guideline (version 1.1)

A systematic review and network meta-analysis of immunotherapy and targeted therapy for advanced melanoma

Magnetic resonance imaging identifies early effects of sunitinib treatment in human melanoma xenografts.

68Ga-TRAP-(RGD)3 Hybrid Imaging for the In Vivo Monitoring of αvß3-Integrin Expression as Biomarker of Anti-Angiogenic Therapy Effects in Experimental Breast Cancer.

P2888

s40644-018-0135-y

P304

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1186/S40644-018-0135-Y

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2018-01-18T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P6179

1100470985

http://www.w3.org/2001/XMLSchema#string

P698

29347968

http://www.w3.org/2001/XMLSchema#string

P932

5774089

http://www.w3.org/2001/XMLSchema#string